查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088937

生物安全檢測產品與服務市場：2026-2032年全球市場預測，依產品、檢測方法、技術、最終用途及服務類型分類

Biological Safety Testing Products & Services Market by Product, Test, Technology, End Use, Service Mode - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 198 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，生物安全檢測產品和服務市場將成長至 149.8 億美元，複合年成長率為 11.51%。

主要市場統計數據
基準年 2025 69.8億美元
預計年份：2026年 77.8億美元
預測年份 2032 149.8億美元
複合年成長率 (%) 11.51%

生物安全檢測產品和服務對於證明生技藥品、疫苗、細胞和基因療法、醫療設備以及關鍵原料符合全球對病人安全、產品品質和污染控制的期望至關重要。該領域依賴經過驗證的檢測方法，這些方法涵蓋無菌性、生物微生物附著量、細菌內毒素、黴漿菌、外源病毒、宿主細胞殘留DNA和蛋白質、細胞毒性、致敏性、刺激性、全身毒性、血液相容性以及相關的生物風險終點。

生物製藥研發管線的不斷擴展、先進療法的湧現、一次性系統的廣泛應用，以及研發和生產整體微生物控制要求的日益嚴格，都進一步推動了市場需求。諸如美國藥典（USP）、ISO 10993、ICH Q5A(R2)、ICH Q5D、ICH Q6B、歐盟GMP附件1、FDA生技藥品指南以及世界衛生組織（WHO）建議等監管和標準框架，繼續為生物安全檢測服務和經驗證的檢測產品奠定基礎。

生物安全測試領域的變革性變化

生物安全檢測領域正從傳統的終點品管轉向基於風險、面向生命週期的安全保障。監管機構越來越要求製造商證明其對原料、細胞基材、製程中間體、設施、公用設施、一次性組件、包裝組件和最終產品等各環節的污染控制，而不僅依賴放行檢測。

人工智慧對檢測工作流程的累積影響

人工智慧正透過實驗室自動化、影像分析、異常檢測、預測性污染控制、電子數據審查以及對In Silico毒理學的支持，開始影響生物安全檢測。權威衛生機構就人工智慧的正確使用、軟體保障和機器學習發表的出版物和討論強調，這些工具必須透明、檢驗、受到監控，並且適合其預期用途。

全球生物安全檢測市場的主要區域趨勢

隨著中國、印度、日本、韓國、新加坡和澳洲在日益成熟的管理體制下不斷擴大其生物製造、疫苗生產、生物相似藥開發和臨床研究能力，亞太地區正成為重要的成長引擎。該地區對生物安全檢測產品和服務的需求，得益於各國制定的生物製藥策略、對先進治療基礎設施的投資，以及對無菌性、內毒素、黴漿菌、外來性微生物和生物相容性檢測等國際標準的採用。

我們小組對東協、海灣合作理事會、歐盟、金磚國家、七國集團和北約的主要觀點。

在東協市場，由於藥品法規的協調統一、臨床試驗的擴展以及政府對本地疫苗、生物相似藥和無菌生產能力的支持，對生物安全檢測的需求正在不斷成長。這些趨勢正在推動整個區域供應鏈對合規性無菌檢測、微生物附著量檢測、內毒素檢測、細胞基材表徵、病毒安全性評估以及醫療設備評估的需求不斷增加。

深入了解影響生物安全檢測需求的關鍵國家。

美國在高度複雜的生技藥品、細胞和基因療法的檢測、生物安全性表徵以及符合FDA標準的品質體系方面處於主導地位，這得益於其完善的GMP基礎設施以及對經驗證的分析和微生物服務的強勁需求。加拿大透過加拿大衛生署的監管和符合國際標準的品質要求，為生技藥品、疫苗和臨床研究的監管提供支援。同時，墨西哥和巴西是拉丁美洲重要的製藥中心，墨西哥已融入北美供應鏈，而巴西的ANVISA（國家衛生監督局）則以其強大的監管能力而聞名。

為行業領導者提供的實用建議

產業領導者應投資於經驗證的快速微生物分析方法、數位化實驗室系統、自動化技術和全球統一的品質管理流程，同時確保符合美國藥典 (USP)、歐洲藥典 (Ph. Eur.)、國際標準化組織 (ISO)、人用藥品註冊技術協調會 (ICH)、美國食品藥品監督機構 (WHO)、歐洲藥品管理局 (企業應嚴格審查供應商，確保關鍵試劑和合約檢測能力的冗餘性，並在整個產品生命週期中實施污染控制策略。

調查方法和證據

本執行摘要基於二手研究和監管信息，涵蓋公開指南、藥典標準、衛生監管機構出版刊物、行業品質框架和公認的科學文獻。支持分析的資訊來源/標準 (PIC/S)、各國衛生監管機構以及生技藥品系統記錄以及現有機構的醫療系統記錄機構以及現有機構系統記錄系統的現有醫療設備記錄系統。

結論：生物製藥的安全性檢測是一項策略性品質問題

生物製藥的安全測試正在發展成為一項策略性品質職能，旨在保護患者、支持監管申報並增強生產韌性。隨著生物製藥、先進療法、疫苗、生物相似藥和醫療設備變得日益複雜，市場對能夠將經過檢驗的科學與速度、合規性、可追溯性和全球擴充性結合的供應商的需求將不斷成長。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章：生物安全檢測產品與服務市場：依產品類別分類

  • 裝置
    • 生物安全櫃
    • ELISA裝置
    • PCR裝置
  • 試劑和試劑盒
    • 培養基
    • ELISA試劑和試劑盒
    • PCR試劑和試劑盒
  • 服務
    • 校對服務
    • 諮詢服務
    • 驗證服務
  • 軟體
    • 資料管理軟體
    • 工作流程自動化軟體

第8章：生物安全檢測產品與服務市場：依檢測類型分類

  • 微生物附著量
    • 平板計數
    • 快速方法
  • 內毒素
    • LAL考試
    • rFC 測試
  • 微生物鑑定
    • MALDI-TOF
    • 基於PCR的
  • 無菌
    • 直接接種
    • 薄膜過濾

第9章：生物安全檢測產品與服務市場：依技術分類

  • 層析法
  • ELISA
  • 質譜分析
  • PCR

第10章：生物安全檢測產品與服務市場：依最終用途分類

  • 學術和研究
  • 生物技術
  • CRO
  • 食品/飲料
  • 醫院/診斷
  • 製藥

第11章：生物安全檢測產品與服務市場：依服務類型分類

  • 內部實施
  • 外包

第12章：生物安全檢測產品與服務市場：按地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第13章：生物安全偵測產品與服務市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第14章：生物安全檢測產品與服務市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第15章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第16章：公司簡介

  • Asahi Kasei Corporation
  • Avance Biosciences Inc.
  • BBF Sterilisationsservice GmbH
  • BSL Bioservice Scientific Laboratories Munich GmbH
  • Charles River Laboratories International, Inc.
  • Creative Biogene
  • Eurofins Scientific SE
  • Labquality Oy
  • Lonza Group AG
  • Merck KGaA
  • North American Science Associates, Inc.
  • NuAire, Inc.
  • Pace Analytical Services, LLC
  • Samsung Biologics
  • Sartorius AG
  • SGS Societe Generale de Surveillance SA
  • Thermo Fisher Scientific Inc.
  • Toyobo Co., Ltd.
  • UL LLC
  • ViruSure GmbH
  • WuXi Biologics Co., Ltd.
Product Code: MRR-A866040826BE

The Biological Safety Testing Products & Services Market is projected to grow by USD 14.98 billion at a CAGR of 11.51% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 6.98 billion
Estimated Year [2026] USD 7.78 billion
Forecast Year [2032] USD 14.98 billion
CAGR (%) 11.51%

Biological safety testing products and services are central to demonstrating that biologics, vaccines, cell and gene therapies, medical devices, and critical raw materials meet global expectations for patient safety, product quality, and contamination control. The field is anchored in validated assays for sterility, bioburden, bacterial endotoxins, mycoplasma, adventitious viruses, residual host-cell DNA and proteins, cytotoxicity, sensitization, irritation, systemic toxicity, hemocompatibility, and related biological risk endpoints.

Demand is being reinforced by expanding biologics pipelines, wider adoption of advanced therapies, increased use of single-use systems, and tighter expectations for microbiological control across development and manufacturing. Regulatory and standards frameworks, including USP chapters, ISO 10993, ICH Q5A(R2), ICH Q5D, ICH Q6B, EU GMP Annex 1, FDA biologics guidance, and WHO recommendations, continue to define the evidence base for biological safety testing services and validated testing products.

Transformative Shifts in the Biological Safety Testing Landscape

The biological safety testing landscape is shifting from traditional end-point quality control toward risk-based, lifecycle-oriented safety assurance. Regulators increasingly expect manufacturers to demonstrate contamination control across raw materials, cell substrates, process intermediates, facilities, utilities, single-use assemblies, packaging components, and final products rather than relying only on release testing.

Rapid microbiological methods, recombinant endotoxin reagents, nucleic acid amplification tests, next-generation sequencing, automated environmental monitoring, digital batch records, and high-throughput analytical platforms are changing how laboratories detect and manage biological risks. At the same time, outsourcing to specialist contract testing organizations is rising as sponsors seek access to validated methods, biosafety expertise, global compliance knowledge, and scalable laboratory capacity while preserving auditability and data integrity.

Cumulative Impact of Artificial Intelligence on Testing Workflows

Artificial intelligence is beginning to influence biological safety testing through laboratory automation, image analytics, anomaly detection, predictive contamination control, electronic data review, and in silico toxicology support. Publications and discussion papers from major health authorities on artificial intelligence, software assurance, and good machine learning practice emphasize that these tools must remain transparent, validated, monitored, and fit for their intended use.

The cumulative impact of AI is strongest where it improves repeatability, traceability, and data integrity, including colony counting, environmental monitoring trend analysis, deviation triage, laboratory scheduling, and quality-system surveillance. However, AI does not replace validated biological assays; it strengthens decision-making when paired with qualified methods, human scientific oversight, audit trails, cybersecurity controls, change management, and regulatory-ready documentation.

Key Regional Insights Across Global Biological Safety Testing Markets

Asia-Pacific is becoming a major growth engine as China, India, Japan, South Korea, Singapore, and Australia expand biomanufacturing, vaccine production, biosimilar development, and clinical research capacity under increasingly mature regulatory systems. The region's demand for biological safety testing products and services is supported by national biopharma strategies, investments in advanced therapy infrastructure, and adoption of international standards for sterility, endotoxin, mycoplasma, adventitious agent, and biocompatibility testing.

North America remains a benchmark for biologics quality expectations because of FDA and Health Canada oversight, advanced contract testing infrastructure, and a high concentration of innovative drug developers, medical device manufacturers, and advanced therapy programs. Latin America is gaining relevance as Brazil and Mexico strengthen pharmaceutical manufacturing, clinical research participation, and health authority oversight, with Brazil's regulatory framework widely recognized for its maturity in the region.

Europe benefits from EMA coordination, EU GMP Annex 1, the Medical Device Regulation, the In Vitro Diagnostic Regulation, national competent authorities, and strong reference laboratory networks, making the region highly influential in biological safety, contamination control, and biocompatibility standards. The Middle East is building local life science capacity through healthcare localization programs, GCC regulatory modernization, and hospital-linked research investments, while Africa is prioritizing vaccine security, diagnostics, and public health laboratory capability with support from Africa CDC, WHO, and regional manufacturing initiatives.

Key Group Insights for ASEAN, GCC, EU, BRICS, G7, and NATO

ASEAN markets are advancing biological safety testing demand through pharmaceutical regulatory harmonization, expanding clinical trials, and government support for local vaccine, biosimilar, and sterile manufacturing capacity. These dynamics increase the need for compliant sterility testing, bioburden testing, endotoxin testing, cell substrate characterization, viral safety evaluation, and medical device biological evaluation across regional supply chains.

The GCC is investing in healthcare localization, biologics access, national medicine security, and regulatory modernization, creating opportunities for microbiology, endotoxin, sterility, and device biocompatibility testing partners that can align with international standards. The European Union provides one of the most structured compliance environments through EMA scientific guidelines, EU GMP Annex 1, MDR, IVDR, pharmacovigilance systems, and harmonized quality expectations across member states.

BRICS countries are strategically important because they combine large patient populations, growing domestic biopharmaceutical capacity, vaccine manufacturing priorities, and increasing regulatory convergence with ICH and WHO-aligned practices. The G7 concentrates many originator biologics developers, advanced testing laboratories, academic research centers, and influential standards-setting bodies, while NATO countries add demand linked to medical readiness, vaccines, diagnostics, biodefense preparedness, emergency stockpiles, and resilient healthcare supply chains.

Key Country Insights Shaping Biological Safety Testing Demand

The United States leads in high-complexity biologics, cell and gene therapy testing, biosafety characterization, and FDA-aligned quality systems, supported by extensive GMP infrastructure and strong demand for validated analytical and microbiological services. Canada supports biologics, vaccine oversight, and clinical research through Health Canada regulation and internationally aligned quality expectations, while Mexico and Brazil serve as important Latin American hubs for pharmaceutical manufacturing, with Mexico integrated into North American supply chains and Brazil's ANVISA recognized for robust regulatory capability.

The United Kingdom, Germany, France, Italy, and Spain anchor European demand through advanced biopharmaceutical manufacturing, medical technology sectors, academic research ecosystems, and strong GMP enforcement. Germany and France are especially influential in biopharma manufacturing and medical technology, the United Kingdom supports advanced therapy research and regulatory innovation, Italy contributes sterile manufacturing and contract development capabilities, and Spain continues to expand clinical research and biotechnology activity, while Russia maintains domestic vaccine and biologics capabilities under national regulatory oversight.

China continues to scale biologics, biosimilars, vaccines, and cell therapy infrastructure under NMPA reforms and closer alignment with international technical standards. India remains a global supplier of vaccines and biosimilars with CDSCO oversight and a broad biologics manufacturing base; Japan maintains a quality-focused environment under PMDA and MHLW; Australia supports clinical research and TGA-regulated product development; and South Korea has become a global biologics manufacturing and biosimilars powerhouse, supported by strong government backing for biotechnology and high-quality manufacturing systems.

Actionable Recommendations for Industry Leaders

Industry leaders should invest in validated rapid microbiological methods, digital laboratory systems, automation, and harmonized global quality procedures while maintaining alignment with USP, Ph. Eur., ISO, ICH, FDA, EMA, PIC/S, and WHO expectations. Companies should qualify suppliers rigorously, build redundancy for critical reagents and contract testing capacity, and apply contamination-control strategies across the full product lifecycle.

Executives should prioritize data integrity, method comparability, technician training, and early regulatory engagement for novel modalities such as viral vectors, mRNA products, engineered cells, microbiome-based therapies, and combination devices. Partnerships with accredited contract testing organizations can reduce bottlenecks when governed by clear quality agreements, transparent method validation, secure data exchange, deviation escalation procedures, and audit-ready documentation.

Research Methodology and Evidence Base

This executive summary is built from secondary research and regulatory intelligence covering publicly available guidance, pharmacopeial standards, health authority publications, industry quality frameworks, and recognized scientific literature. Sources informing the analysis include FDA, EMA, WHO, ICH, ISO, USP, European Pharmacopoeia, OECD, PIC/S, national health authorities, and documented trends in biologics, vaccines, advanced therapies, and medical device quality systems.

The methodology prioritizes verified, traceable, and compliance-relevant insights rather than unsubstantiated commercial claims. Findings are synthesized through cross-regional comparison of regulatory expectations, manufacturing capacity, technology adoption, outsourcing patterns, contamination-control requirements, and quality-system obligations affecting biological safety testing products and services.

Conclusion: Biological Safety Testing as a Strategic Quality Imperative

Biological safety testing is evolving into a strategic quality function that protects patients, supports regulatory submissions, and strengthens manufacturing resilience. As biologics, advanced therapies, vaccines, biosimilars, and medical devices become more complex, demand will favor providers that combine validated science with speed, compliance, traceability, and global scalability.

Organizations that modernize testing platforms, integrate artificial intelligence responsibly, strengthen supplier qualification, and align with international standards will be better positioned to manage biological risk across the product lifecycle. The strongest competitive advantage will come from defensible data, reliable turnaround times, robust quality systems, and end-to-end biosafety expertise.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Biological Safety Testing Products & Services Market, by Product

  • 7.1. Instruments
    • 7.1.1. Biosafety Cabinets
    • 7.1.2. ELISA Instruments
    • 7.1.3. PCR Instruments
  • 7.2. Reagents & Kits
    • 7.2.1. Culture Media
    • 7.2.2. ELISA Reagents & Kits
    • 7.2.3. PCR Reagents & Kits
  • 7.3. Services
    • 7.3.1. Calibration Services
    • 7.3.2. Consulting Services
    • 7.3.3. Validation Services
  • 7.4. Software
    • 7.4.1. Data Management Software
    • 7.4.2. Workflow Automation Software

8. Biological Safety Testing Products & Services Market, by Test

  • 8.1. Bioburden
    • 8.1.1. Plate Count
    • 8.1.2. Rapid Methods
  • 8.2. Endotoxin
    • 8.2.1. LAL Test
    • 8.2.2. rFC Test
  • 8.3. Microbial Identification
    • 8.3.1. MALDI-TOF
    • 8.3.2. PCRBased
  • 8.4. Sterility
    • 8.4.1. Direct Inoculation
    • 8.4.2. Membrane Filtration

9. Biological Safety Testing Products & Services Market, by Technology

  • 9.1. Chromatography
  • 9.2. ELISA
  • 9.3. Mass Spectrometry
  • 9.4. PCR

10. Biological Safety Testing Products & Services Market, by End Use

  • 10.1. Academic & Research
  • 10.2. Biotechnology
  • 10.3. CRO
  • 10.4. Food & Beverage
  • 10.5. Hospitals & Diagnostics
  • 10.6. Pharmaceutical

11. Biological Safety Testing Products & Services Market, by Service Mode

  • 11.1. In House
  • 11.2. Outsourced

12. Biological Safety Testing Products & Services Market, by Region

  • 12.1. Asia-Pacific
  • 12.2. North America
  • 12.3. Latin America
  • 12.4. Europe
  • 12.5. Middle East
  • 12.6. Africa

13. Biological Safety Testing Products & Services Market, by Group

  • 13.1. ASEAN
  • 13.2. GCC
  • 13.3. European Union
  • 13.4. BRICS
  • 13.5. G7
  • 13.6. NATO

14. Biological Safety Testing Products & Services Market, by Country

  • 14.1. United States
  • 14.2. Canada
  • 14.3. Mexico
  • 14.4. Brazil
  • 14.5. United Kingdom
  • 14.6. Germany
  • 14.7. France
  • 14.8. Russia
  • 14.9. Italy
  • 14.10. Spain
  • 14.11. China
  • 14.12. India
  • 14.13. Japan
  • 14.14. Australia
  • 14.15. South Korea

15. Competitive Landscape

  • 15.1. Market Concentration Analysis, 2025
    • 15.1.1. Concentration Ratio (CR)
    • 15.1.2. Herfindahl Hirschman Index (HHI)
  • 15.2. Recent Developments & Impact Analysis, 2025
  • 15.3. Product Portfolio Analysis, 2025
  • 15.4. Benchmarking Analysis, 2025

16. Company Profiles

  • 16.1. Asahi Kasei Corporation
  • 16.2. Avance Biosciences Inc.
  • 16.3. BBF Sterilisationsservice GmbH
  • 16.4. BSL Bioservice Scientific Laboratories Munich GmbH
  • 16.5. Charles River Laboratories International, Inc.
  • 16.6. Creative Biogene
  • 16.7. Eurofins Scientific SE
  • 16.8. Labquality Oy
  • 16.9. Lonza Group AG
  • 16.10. Merck KGaA
  • 16.11. North American Science Associates, Inc.
  • 16.12. NuAire, Inc.
  • 16.13. Pace Analytical Services, LLC
  • 16.14. Samsung Biologics
  • 16.15. Sartorius AG
  • 16.16. SGS Societe Generale de Surveillance SA
  • 16.17. Thermo Fisher Scientific Inc.
  • 16.18. Toyobo Co., Ltd.
  • 16.19. UL LLC
  • 16.20. ViruSure GmbH
  • 16.21. WuXi Biologics Co., Ltd.

LIST OF FIGURES

  • FIGURE 1. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL BIOSAFETY CABINETS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL BIOSAFETY CABINETS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL BIOSAFETY CABINETS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL ELISA INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL ELISA INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL ELISA INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL PCR INSTRUMENTS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL CULTURE MEDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL CULTURE MEDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL ELISA REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL ELISA REAGENTS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL ELISA REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL PCR REAGENTS & KITS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL PCR REAGENTS & KITS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL PCR REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL CALIBRATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL CALIBRATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL CALIBRATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL CONSULTING SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL CONSULTING SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VALIDATION SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VALIDATION SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VALIDATION SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL WORKFLOW AUTOMATION SOFTWARE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL WORKFLOW AUTOMATION SOFTWARE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL WORKFLOW AUTOMATION SOFTWARE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL BIOBURDEN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL BIOBURDEN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL BIOBURDEN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL PLATE COUNT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL PLATE COUNT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL PLATE COUNT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL RAPID METHODS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL RAPID METHODS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL RAPID METHODS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL ENDOTOXIN MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL ENDOTOXIN MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL ENDOTOXIN MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL LAL TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL LAL TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL LAL TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL RFC TEST MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL RFC TEST MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL RFC TEST MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL MICROBIAL IDENTIFICATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL MALDI-TOF MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL MALDI-TOF MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL MALDI-TOF MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL PCRBASED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PCRBASED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PCRBASED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL STERILITY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL STERILITY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL STERILITY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL DIRECT INOCULATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL DIRECT INOCULATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL DIRECT INOCULATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL MEMBRANE FILTRATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL MEMBRANE FILTRATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL MEMBRANE FILTRATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL CHROMATOGRAPHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL ELISA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL ELISA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL MASS SPECTROMETRY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL PCR MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL PCR MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL ACADEMIC & RESEARCH MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL ACADEMIC & RESEARCH MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL ACADEMIC & RESEARCH MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL BIOTECHNOLOGY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL CRO MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL CRO MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL CRO MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL FOOD & BEVERAGE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL FOOD & BEVERAGE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL FOOD & BEVERAGE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL HOSPITALS & DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL HOSPITALS & DIAGNOSTICS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL HOSPITALS & DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL PHARMACEUTICAL MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL PHARMACEUTICAL MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL PHARMACEUTICAL MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL IN HOUSE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL IN HOUSE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL IN HOUSE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL OUTSOURCED MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL OUTSOURCED MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL OUTSOURCED MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 139. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 140. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 141. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 142. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 143. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 144. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 153. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 154. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 155. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 156. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 157. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 158. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 159. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 160. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 167. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 168. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 169. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 170. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 171. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 172. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 173. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 174. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 175. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 176. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 181. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 182. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 183. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 184. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 185. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 186. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 187. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 188. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 189. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 190. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 191. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 192. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 195. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 196. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 197. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 198. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 199. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 200. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 201. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 202. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 203. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 204. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 205. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 206. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 207. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 208. AFRICA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 211. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 212. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 213. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 214. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 215. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 216. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 217. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 218. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 219. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 220. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 221. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 222. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 223. ASEAN BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 224. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 225. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 226. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 227. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 228. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 229. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 230. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 231. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 232. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 233. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 234. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 235. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 236. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 237. GCC BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 238. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 239. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 240. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 241. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 242. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 243. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 244. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 245. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 246. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 247. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 248. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 249. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 250. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 251. EUROPEAN UNION BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 252. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 253. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 254. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 255. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 256. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 257. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 258. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 259. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 260. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 261. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 262. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 263. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 264. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 265. BRICS BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 266. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 267. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 268. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 269. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 270. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 271. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 272. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 273. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 274. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 275. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 276. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 277. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 278. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 279. G7 BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 280. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 281. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 282. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 283. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 284. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 285. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 286. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 287. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 288. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 289. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 290. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 291. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 292. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 293. NATO BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 294. GLOBAL BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 295. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 296. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 297. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 298. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 299. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 300. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 301. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 302. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 303. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 304. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY MICROBIAL IDENTIFICATION, 2018-2032 (USD MILLION)
  • TABLE 305. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY STERILITY, 2018-2032 (USD MILLION)
  • TABLE 306. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 307. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY END USE, 2018-2032 (USD MILLION)
  • TABLE 308. UNITED STATES BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICE MODE, 2018-2032 (USD MILLION)
  • TABLE 309. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 310. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY PRODUCT, 2018-2032 (USD MILLION)
  • TABLE 311. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY INSTRUMENTS, 2018-2032 (USD MILLION)
  • TABLE 312. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY REAGENTS & KITS, 2018-2032 (USD MILLION)
  • TABLE 313. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SERVICES, 2018-2032 (USD MILLION)
  • TABLE 314. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY SOFTWARE, 2018-2032 (USD MILLION)
  • TABLE 315. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY TEST, 2018-2032 (USD MILLION)
  • TABLE 316. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY BIOBURDEN, 2018-2032 (USD MILLION)
  • TABLE 317. CANADA BIOLOGICAL SAFETY TESTING PRODUCTS & SERVICES MARKET SIZE, BY ENDOTOXIN, 2018-2032 (USD MILLION)
  • TABLE 318. CA